Ebola-Specific CD8 + and CD4 + T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae
暂无分享,去创建一个
Kayla Shore | D. Grant | A. Goba | Mambu Momoh | Lansana D. Kanneh | Michael Gbakie | A. Oldstone | B. Cubitt | M. Boisen | Saori Sakabe | F. Garry | Foday Al-Hassan | Mohamed Yilah | Ashley Smira | I. Bica | M. Lavergne | Demby Sandi | M. Mayeux | Michael Pollard | M. Branco | S. Schieffelin | M. Sullivan | L. Kanneh
[1] Pardis C Sabeti,et al. Identification of Common CD8+ T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone , 2020, Journal of Virology.
[2] Pardis C Sabeti,et al. High crossreactivity of human T cell responses between Lassa virus lineages , 2020, PLoS pathogens.
[3] J. Sidney,et al. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection , 2019, Cell.
[4] J. Neaton,et al. A Longitudinal Study of Ebola Sequelae in Liberia , 2019, The New England journal of medicine.
[5] Karthik Gangavarapu,et al. Analysis of CD8+ T cell response during the 2013–2016 Ebola epidemic in West Africa , 2018, Proceedings of the National Academy of Sciences.
[6] E. Kenu,et al. Post-Ebola Syndrome among Ebola Virus Disease Survivors in Montserrado County, Liberia 2016 , 2018, BioMed research international.
[7] Dianna D. Carroll,et al. Trust, fear, stigma and disruptions: community perceptions and experiences during periods of low but ongoing transmission of Ebola virus disease in Sierra Leone, 2015 , 2018, BMJ Global Health.
[8] A. Adebajo,et al. Musculoskeletal manifestations of Ebola virus , 2018, Rheumatology.
[9] Livia Navon. Using Emergency Medical Services (EMS) Data to Assess Personal Protective Equipment (PPE) Reporting By Illinois EMS Providers in Response to the 2014–2016 Ebola Outbreak in West Africa , 2017 .
[10] Mohamed A. Vandi,et al. Sequelae and Other Conditions in Ebola Virus Disease Survivors, Sierra Leone, 2015 , 2017, Emerging infectious diseases.
[11] Jay B. Varkey,et al. Ebola Virus Persistence in Semen of Male Survivors. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] R. Fowler,et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. , 2016, The Lancet. Infectious diseases.
[13] A. Chughtai,et al. Recurrence and reinfection--a new paradigm for the management of Ebola virus disease. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[14] Jay B. Varkey,et al. Human Ebola virus infection results in substantial immune activation , 2015, Proceedings of the National Academy of Sciences.
[15] F. Ennis,et al. Cross-reactive human B cell and T cell epitopes between influenza A and B viruses , 2013, Virology Journal.
[16] M. Whitt. Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. , 2010, Journal of Virological Methods.
[17] Bjoern Peters,et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities , 2007, Proceedings of the National Academy of Sciences.
[18] Claudio Michelassi,et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. , 2004, Seminars in arthritis and rheumatism.
[19] A. Sanchez,et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. , 1999, The Journal of infectious diseases.
[20] J Bertolli,et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. , 1999, The Journal of infectious diseases.
[21] R. Colebunders,et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. , 1999, The Journal of infectious diseases.
[22] P. Simmonds,et al. Extrahepatic Immunologic Manifestations in Chronic Hepatitis C and Hepatitis C Virus Serotypes , 1995, Annals of Internal Medicine.
[23] M. Tsang,et al. Aggregation of the chemokine MIP-1 alpha is a dynamic and reversible phenomenon. Biochemical and biological analyses. , 1994, The Journal of biological chemistry.
[24] T. Delbanco,et al. The rheumatoid factor: an analysis of clinical utility. , 1991, The American journal of medicine.
[25] S. Podos. Ocular Differential Diagnosis , 1972 .
[26] M. Oldstone. VIRUS INDUCED AUTOIMMUNE DISEASE: VIRUSES IN THE PRODUCTION AND PREVENTION OF AUTOIMMUNE DISEASE , 1972 .